Establishment Labs appoints Taylor Harris to board of directors

Establishment Labs has appointed Taylor Harris to its board of directors. Harris brings extensive experience, having most recently served as CEO of Cutera and held CFO roles at MyoKardia, Zeltiq Aesthetics, and Thoratec, where he guided companies through significant acquisitions. Additionally, he spent over a decade in healthcare equity research and investment banking at JPMorgan Chase.

Establishment Labs appointed Taylor Harris to its board of directors. * Harris most recently served as CEO of Cutera. * He previously held CFO roles at MyoKardia, Zeltiq Aesthetics, and Thoratec, guiding each through acquisitions, including MyoKardia’s $13.1 billion sale. * He spent more than a decade at JPMorgan Chase in healthcare equity research and investment banking. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Establishment Labs Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260629901894) on June 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)